BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 17681352)

  • 1. DNA topoisomerase II, genotoxicity, and cancer.
    McClendon AK; Osheroff N
    Mutat Res; 2007 Oct; 623(1-2):83-97. PubMed ID: 17681352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide, topoisomerase II and cancer.
    Baldwin EL; Osheroff N
    Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):363-72. PubMed ID: 16101488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.
    Deweese JE; Osheroff N
    Nucleic Acids Res; 2009 Feb; 37(3):738-48. PubMed ID: 19042970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
    Fortune JM; Osheroff N
    Prog Nucleic Acid Res Mol Biol; 2000; 64():221-53. PubMed ID: 10697411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors.
    Vann KR; Oviatt AA; Osheroff N
    Biochemistry; 2021 Jun; 60(21):1630-1641. PubMed ID: 34008964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerases as anticancer targets.
    Delgado JL; Hsieh CM; Chan NL; Hiasa H
    Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of divalent metal ions by type II topoisomerases.
    Deweese JE; Osheroff N
    Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).
    Withoff S; De Jong S; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1867-80. PubMed ID: 8712715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.
    Burden DA; Osheroff N
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):139-54. PubMed ID: 9748545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Topoisomerases.
    Bush NG; Evans-Roberts K; Maxwell A
    EcoSal Plus; 2015; 6(2):. PubMed ID: 26435256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic function of DNA topoisomerase II.
    Osheroff N; Zechiedrich EL; Gale KC
    Bioessays; 1991 Jun; 13(6):269-73. PubMed ID: 1654050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic DNA topoisomerase II beta.
    Austin CA; Marsh KL
    Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From DNA damage to G2 arrest: the many roles of topoisomerase II.
    Larsen AK; Escargueil AE; Skladanowski A
    Prog Cell Cycle Res; 2003; 5():295-300. PubMed ID: 14593724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA supercoiling and relaxation by ATP-dependent DNA topoisomerases.
    Fisher LM; Austin CA; Hopewell R; Margerrison EE; Oram M; Patel S; Plummer K; Sng JH; Sreedharan S
    Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):83-91. PubMed ID: 1351300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for tumor cell killing by topoisomerase poisons.
    Zhang H; D'Arpa P; Liu LF
    Cancer Cells; 1990 Jan; 2(1):23-7. PubMed ID: 2167111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.